TriangleHEALTH PROFESSIONAL · SOURCE READING
High-dose etoposide and cyclophosphamide
Source: Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: March 14, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Refractory or Recurrent AML / Chemotherapy / Intensive salvage chemotherapy
Evidence (high-dose etoposide and cyclophosphamide):
Reported results have been similar to those for the combination of cytarabine and mitoxantrone.[9]
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice